Guizhou Bailing Group Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Bailing Group Pharmaceutical Company Limited with three other
companies in this sector in CHINA :
Xiangxue Pharmaceutical Co Ltd
sales of 2.79 billion Chinese Renmimbi [US$399.57 million]
of which 49%
was Chinese Herbal Medicines),
Gan & Lee Pharmaceuticals Co Ltd
(2.89 billion Chinese Renmimbi [US$415.02 million]
of which 97%
was Insulin and related products), and
Sihuan Pharmaceutical Holdings Group Ltd
(2.89 billion Chinese Renmimbi [US$414.02 million]
of which 100%
was Manufaturing and Sale of Pharmaceutical ).
During the year ended December of 2019, sales at
Guizhou Bailing Group Pharmaceutical Company Limited were 2.85 billion Chinese Renmimbi (US$408.80 million).
decrease of 9.1%
versus 2018, when the company's sales were 3.14 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 26.0% decline
in Other, from 10.15 million Chinese Renmimbi to 7.50 million Chinese Renmimbi.
There were also decreases in sales in
Industry (down 12.1% to 2.40 billion Chinese Renmimbi)
Medical Institution (down 20.3% to 52.97 million Chinese Renmimbi)
Other Business (down 10.1% to 6.00 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Business (up 33.5% to 492.70 million Chinese Renmimbi)